Original Research
Published on 16 Nov 2022
Psychological distress and resilience in patients with gastroenteropancreatic neuroendocrine tumor
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.947998
- 2,969 views
- 10 citations
Type at least 3 characters
1,192 articles
Articles
Review
Published on 15 Nov 2022
Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1029210
- 6,377 views
- 10 citations
Systematic Review
Published on 11 Nov 2022
Endocrine and paracrine characteristics of neuroendocrine prostate cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1012005
- 5,448 views
- 9 citations
Original Research
Published on 09 Nov 2022
Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.963382
- 3,206 views
Original Research
Published on 07 Nov 2022
JMJD6 orchestrates a transcriptional program in favor of endocrine resistance in ER+ breast cancer cells
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1028616
- 3,494 views
- 6 citations
Original Research
Published on 03 Nov 2022
A 5-year follow-up study on the efficacy and safety of ultrasound-guided laser ablation in elderly patients with papillary thyroid microcarcinoma: A retrospective, single-center study from China
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.972589
- 2,405 views
- 2 citations
Original Research
Published on 03 Nov 2022
Insulin resistance and inflammation mediate the association of abdominal obesity with colorectal cancer risk
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.983160
- 3,704 views
- 10 citations
Review
Published on 31 Oct 2022
The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.941832
- 16,822 views
- 25 citations
Original Research
Published on 27 Oct 2022
Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1047433
- 5,177 views
- 7 citations
Original Research
Published on 26 Oct 2022
Prognostic model for the exemption of adjuvant chemotherapy in stage IIIC endometrial cancer patients
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.989063
- 1,538 views
- 1 citation
Original Research
Published on 25 Oct 2022
The spoke wheel color Doppler blood flow signal is a specific sign of papillary thyroid carcinoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1030143
- 7,889 views
- 5 citations
Original Research
Published on 24 Oct 2022
Nomogram for preoperative estimation of histologic grade in gastrointestinal neuroendocrine tumors
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.991773
- 1,819 views
- 3 citations
Editorial
Published on 24 Oct 2022
Editorial: Architects of Endocrine-Related Tumour Growth
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1046478
- 925 views
Original Research
Published on 24 Oct 2022
Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.963220
- 12,726 views
- 33 citations
Original Research
Published on 21 Oct 2022
A combined signature of glycolysis and immune landscape predicts prognosis and therapeutic response in prostate cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1037099
- 3,024 views
- 2 citations
Systematic Review
Published on 20 Oct 2022
Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review
in Cancer Endocrinology
![Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review](https://www.frontiersin.org/files/myhome article library/957172/957172_Thumb_400.jpg)
Frontiers in Endocrinology
doi 10.3389/fendo.2022.957172
- 3,027 views
- 12 citations